RecruitingNCT07717255

Adequacy of Haemodiafiltration: Middle Molecules Clearance, Patients Reported Outcomes and Sodium Balance

Sponsor

East and North Hertfordshire NHS Trust

Enrollment

300 participants

Start Date

Jan 9, 2025

Study Type

OBSERVATIONAL

Conditions

Haemodiafiltration Malnutrition (Calorie)Nutrition Haemodialysis Fluid Balance Outcomes Patient Reported Outcome Measurements

Summary

The goal of this observational study is to understand the differences in terms of middle molecules clearance and patient outcomes in High (\>23Litres (L)) vs Low (\<23 L) convection volume (CV) Hemodiafiltration (HDF) and to understand the effect of dialysate fluid sodium concentration (137 vs 140 mmol/L) on overhydration volume in patients on HD and HDF.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with fluid balance outcomes, haemodiafiltration, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.